Dysregulation of the ERK1/2, JNK1/2/3, and p38α/β/γ/δ pathways has been causally linked to human congenital syndromes and to a variety of diseases including cancer, arthritis, fibrosis, cardiomyopathies, and neurodegenerative diseases. Here, MAPK3 is linked to cancer.